Impact of Pre-Transplant Molecular Measurable Residual Disease (MMRD) and European Leukemianet (ELN) Genetic Classification in Clinical Outcomes for Acute Myeloid Leukemia (AML) Patients (Pts) Undergoing Allogeneic Stem Cell Transplantation (alloHCT) | Publicación